ValiRx Share Chat (VAL)

0.20...-0.041 (-17.01%) ...Bid: 0.19...Ask: 0.21...Spread: 0.02 (10.526%)

Market Cap: £1.49m

-98.41% down now , very big loss.

15/5/26 Placing at 0.2 pence.

https://www.google.com/finance/beta/quote/VAL:LON?window=MAX

ValiRx shares drop 17% as life sciences group raises £1.16m at steep discount

ValiRx, the AIM-listed life sciences company focused on early-stage cancer therapeutics and women's health, has raised up to £1.155 million through a placing, subscription, and planned retail offer at 0.2p per share.

The shares fell 17% to 0.2p, matching the issue price, which itself represented a 17% discount to the previous closing price.

£150,000 to follow via a retail offer open to smaller investors.

Subscribers will also receive one warrant for every new share acquired, exercisable at 0.28p, a 40% premium to the issue price, subject to shareholder approval at the company's annual general meeting in June.

Share Price. 0.305...0.00 (0.00%) ...Bid: 0.29..Ask: 0.32...Spread: 0.03 (10.345%)

Market Cap: £2.27m

Much the same as my last look in December .

-97.74% down massive loss in cash terms .

https://markets.investorschronicle.co.uk/data/equities/tearsheet/summary?s=VAL:LSE

Ist December 2025 ..Share Price: 0.28..Bid: 0.27...Ask: 0.29...Change: -0.065 (-18.84%) ...Spread: 0.02 (7.407%)

Small Director buy £3300 last month .

Purchase..3 Mar 2026 Mark Edward Eccleston Executive Director,Chief Executive Officer

I topped up this morning.My average was 7+p, but now it's down to 2p.

Lots of late reported buys again

I was in this share from 2009 until 2018 (still have some left actually), from the time I joined when the share was around 0.60p and now it is worth probably 0.000xxx something, dilution after dilution. I have only one thing to say about this share, IF YOU ARE NOT A TRADER THEN STAY MILES MILES AWAY FROM THIS SHARE. I used to hate deramper but many of you should thanks Porky9 and Lunatic (which I know them both for years ago).

RayPointer, for your baby share SCLP you must also admit that it is not doing well in the last 10 years at least, but at least the share price does not fluctuate a lot like VAL.

The dedicated few were talking warrants being taken up, lucrative deals and no need for a placing at all, but sufficient funds well into H2. Porky getting the price a few points out and a few weeks later than predicted is pretty accurate compared to the forecasts of those who were utterly dismissive of his forecast. Let's hope any potential new share buyers took heed of what he said rather than falling for the insidious rampfest.

Pretty sure Porky was claiming a much lower price for the placing so I’m not sure why everyone is celebrating his success. As these things go, we’ve seen much worse previously. This isn’t even conditional on a vote because they kept the price high enough and looks like it’ll be enough until this time next year as we know the coffers weren’t empty

I think you'll find the ramp crew will go awol for a couple of weeks, then reappear with the same lines and abuse as before, and brushing off the (latest) placing as something low key, necessary and in the past. Same as they did not many months ago at the last placing. And the one before that. But maybe this time they'll be gracious enough to thank Porky9 for warning them about what was coming, and apologise for being so rude to him when he was right after all.

Ray,

Clearly management are underpaid... hopefully Team Ramp are busy today trying to ensure that management receive a significant pay raise for successfully getting this placing away. That way they will have more spare cash to participate in the next placing....

Or maybe Team Ramp are a little upset and sulking after being adamant that when the CEO said that the cash runway lasted into H2 it meant that there would be no placing until H2.

Fair point

decent from here, until the next placing at 0.10.

this business has no model, just pumped up rns to trap naive investors

buy the dip / alias afzal what an absolute ****/end in every way possible, a pure paid ramper, same in all his stocks he pumps here and on telegram

he buys, then pumps it, tries to get the price up and sells whilst you mugs are buying

should have watched the pumping yesterday by this **** end in talisam, he picked up 2 x 100,000 at 7p sold them at 8.00 as you lot were buying

an absolute turd

so many of you get suckered in makes my so andry

Porky9

Member since Oct 2020

Posts: 7,507

Price: 0.235

RE: Placing?14 May 2026 12:19

They will try and sell into it first ahead of the placing, knowing they can get stock back with the new issue thats what has happened EVERY last placing so expect this one to be the same.

Stand by my .15 placing estimate - will see

ReplyRecommend (5)Report Post

Called it correctly yet again Porky.Anyone over the years that followed your advice instead of verbally abusing you will have saved a lot of money . Me still watching and waiting with this one…been a couple of years now

They will try and sell into it first ahead of the placing, knowing they can get stock back with the new issue thats what has happened EVERY last placing so expect this one to be the same.

Stand by my .15 placing estimate - will see

Looks like someone bored and moving on.

The bid is currently below the price of the last placing - what might the next one be priced at? 0.2 looks pretty unlikely now, and I presume it isn't allowed ot be below the nominal value of the shares. Maybe paternostpauper can give us his thoughts as what looks to be a critical point looms larger.

AIM is full of life style companies like this

but no one there to police it properly

it should be stopped

500,000,000 NEW SHARES to hit the market. And how many did the directors buy? They put in a token amount, not one months salary. Obviously the directors do not know if the company will survive so they put little in. No one wants these so called drugs. This is like a charity. You give them cash and they are back for more with little or anything to show. They have nearly doubled the amount of shares in issue so anyone holding before today has been diluted and shafted again. And know doubt there will be some fools willing to buy shares in this company or God forbid top up and average down. In 6 months and no doubt before Christmas they will issue 1,000,000,000 billion shares and get very little cash for it. When people refuse this paper they will only delist. No one is interesting in their drugs ar research. Its a charity where you give them cash and then say good bye to your money.

They raised this amount just 6 months ago. Obviously then in 6 months if nothing changes they will do another raise but at a lower price. Shafting holders time and time again. Who wants to buy now and wait for the next shafting?

The directors bought little shares in this raise for obvious reasons. AVOID

Probably 50% discount 0.1 and it will probably their last as they will have to issue too many shares as the share price is so low they will raise too little to keep going. Always kept afloat by placings and it looks like nothing has changed.

No one is interested in their orphan drugs. This is going nowhere except down. Anyone who invested here has lost, do not be tricked in topping up or buying off the bottom. Eventually this is going to go under and be delisted. Hopeless company

He has understood more about Valrix than even the CEO did while running it. I suggest conducting an investigation into the company dating back to when Suzy Dilly was in charge. It may be possible to connect everything involving Suzy, Nick, and Mark.

It seems like Epstein files in here too lol 😂

For years I continue to hold this absolute dog of a company in my portfolio as a constant reminder of how badly things you go wrong on AIM. And I was buying on big dips. A leopard doesn't change its spots. You have been warned.

Porky yesterday- i will stick with my 0.15 placing estimate. Today, placing at 0.2 .Rat today - porky called it right again.you couldnt make it up,dumb and dumber.

ABSOLUTE DISASTER, 6 MONTHS AND MORE AND MORE PLACINGS>

I PREDICT NEXT ONE DECEMBER 2026 AT 0.10 p.....

Shocking! retail offer with no positive news just an invitation to dump after institutional forward selling.

Yes very disappointing after all the promises year after year. Looks like I have lost my money as every few months another placing and no income .☹️

'This fundraising is intended to support in-licensing activities, intellectual property expansion, preclinical development, and the growth of ValiRx Animal Health.'

The placing will more or less cover day to day running costs and not a lot else.

Well done Porky - you called it right yet again.

Listening to that pumper " BUY THE DIP" AFZAL VALLI - The biggest pumper out there

Should be banned

Obviously leaked yesterday hence drop ,so wrong .

Ok Notpotalot, so what you're saying is you are underwater and have been for the last 6 months, and now heading for a placing. Much clearer when it's phrased like that.

Nom, my first post was indeed Oct ’24 and I bought in on 14th Jan’25 when the SP was approx 0.73p. Check my history – only takes a few secs - 39.2p lower than you claim.

Having averaged down heavily following the recent placing, I was actually in profit only last Nov. I expect to be back in profit again shortly.

Talk of desperation. Do you really need to spread total lies in your quest? Shame on you!

GLA, DYOR, AIMO

Notpotalot,

Do you remember posting sarcastically in October 2024: "As a somewhat overawed admirer, I have followed Porky from afar for the last 4 years. Many times, I have wanted to acknowledge his profound mastery of the stock market and its mysteries, so elusive to most mortals".

The share price was around 40p then - any shares you held since then would be down 99.4%. Well done you.

More to the point, will there be a Val to invest in?

Anyway, it's lovely to see you posting again, Notpotalot. We all thought you had lost your job.

Porky, does this mean you and Rat aren't going to invest in Val after all?

I’m utterly paralysed by indifference. 🤣🤣🤣

GLA, DYOR

Nothing whatsoever. Pipeline or opportunity aside just zoom out on the chart from April 2020 to current day and this tells you everything you need to know.

Loads of what in the pipeline?

Perhaps you need to do some research.

Good luck!

Loads in the pipeline? Looking for non dilutive grants and funding?

£2mil MCAP ARL massive gaps to ATH?

Given the lack of dreamworld posts for over well over a week, it seems that maybe the hype crew have come to their senses and stopped trying to polish a Richard the Third. Perhaps we can wait for the placing and then see where they think the company is headed, rather than having the Halelujah chorus every time an RNS comes out saying the office cleaner has won a tenner on the lottery.

I wouldn’t touch Val

I think we need to raise imminently looking at the last balance sheet and raise .

Will be an almighty ramp but as I said a few months ago ,May is likely to be placing month as I think money will be v v low .

So if you’re prepared to lose 50pct overnight ..go for it !!

Cruiseship,pharmas taking off ,very cheap here .

Wow Spre, that’s a great return! 🤣

I'm sure paternostpauper will spend the weekend trying to convince you 'it's all very different now' and 'it isn't a loss if you don't sell', and other one-liners which aren't funny when it's your own money.

Sorry to hear you got fleeced by this crew.

just looked, my £5000 investment is now worth 18p.

not bad.

is that fat **** george still alive?

Https://en.wikipedia.org/wiki/Investigational_New_Drug

Pater, make yourself useful and ask ME for a CLX progress report on each of the 5 items listed below.

"The IND application may be divided into the following categories:

1) Preclinical testing consists of animal pharmacology and toxicology studies to assess whether the drug is safe for testing in humans. Also included are any previous experience with the drug in humans (often foreign use).

2) Manufacturing Information includes composition, manufacturer, and stability of, and the controls used for, manufacturing the drug. Used to ensure that the company can adequately produce and supply consistent batches of the drug.

3) Investigator information on the qualifications of clinical investigators, that is, the professionals (generally physicians) who oversee the administration of the experimental drug to the study subjects. Used to assess whether the investigators are qualified to fulfill their clinical trial duties.

4)Clinical trial protocols are the centerpiece of the IND. Detailed protocols for proposed clinical studies to assess whether the initial-phase trials will expose the subjects to unnecessary risks.

5) Other commitments are commitments to obtain informed consent from the research subjects, to obtain a review of the study by an institutional review board (IRB), and to adhere to the investigational new drug regulations."

Suzy Dilly has done serious damage to this company. She misrepresented her abilities just to hold onto her position long enough to sort out her personal situation. Adam has ended up being the biggest loser in all of this so far. Porky, on the other hand, was the most accurate,he predicted almost everything spot on. Nick was the most cunning; he managed to get out just before things started to collapse, likely thanks to some well-timed insider information. As for the rest, they seem to be stuck in denial, just waiting around day after day 🐑 bahah. This company doesn’t even worth value of my house Jesus loves you all 😂

2 million pharma in talks with majors

I only post when I reply to you notpotalot.

Hopefully it’s saved investors a lot of money as I’ve cautioned this share esp as costs us 110k to have ME secretary !

I know Adrian ,Adam h ,uncanny have all thanked me having read my posts / thoughts and sold out . So I’m delighted to have saved them money.

When we have a CEO who won’t cut costs enough and keeps breaking promises you know what’s to come !

He’s over promised and under delivered .

Mug punters paying for excessive salaries with zero delivery need to see a dr. You included Notpotalot.

Try getting the 23 likes to buy stock ! Then Val price won’t be at all time lows 33p to 0.26p . You couldn’t make it up

May is a very important month for VAL imho .

Off for a walk. What a fabulous sunny day. X

I only post when I reply to you notpotalot.

Hopefully it’s saved investors a lot of money as I’ve cautioned this share esp as costs us 110k to have ME secretary !

I know Adrian ,Adam h ,uncanny have all thanked me having read my posts / thoughts and sold out . So I’m delighted to have saved them money.

When we have a CEO who won’t cut costs enough and keeps breaking promises you know what’s to come !

He’s over promised and under delivered .

Mug punters paying for excessive salaries with zero delivery need to see a dr. You included Notpotalot.

Try getting the 23 likes to buy stock ! Then Val price won’t be at all time lows 33p to 0.26p . You couldn’t make it up

May is a very important month for VAL imho .

Off for a walk. What a fabulous sunny day. X

Notpotalot is 100% correct when he states 'A CEO’s role is to build long term shareholder value'.

Dr. Mark Eccleston was officially appointed as the Chief Executive Officer of ValiRx plc on August 12, 2024 when the share price was 2.35p. Most would judge the 88% decline in share price over the 20 months he has been CEO as a destruction of shareholder value. I am grateful for Notpotalot to have taken off his rampers hat and honestly lay out a CEOs role.

#Respect

“Invested crew" = those with a vested interest in ramping due to being heavily underwater. But definitely a 'crew' in the finest AIM jungle terms.

“Uninvested historians” = those with a wider view and no axe to grind.

Rat: “Paternost and his crew post stuff week in week out”

Val posts in last 30 days:

“Invested crew’: Notpot (15), Paternost (9) = 24 Total

“Uninvested historians”: Rat (27), Ray P (15), Viera (13), Porky (10) = 65 Total

Nuff said! 🤣🤣🤣

Incidentally Pinfinder, why don't you post 'PLEASE DO NOT TAKE THIS SERIOUSLY WITHOUT SEEING SOME RELIABLE EVIDENCE' when Paternost and his crew post stuff week in week out that's full of unsustainable conjecture?

Ignore his comment then perhaps, but look at the RNS - still about 5 months left to evaluate a delivery system (which will have a chance of failure by its nature, otherwise it wouldn't need testing) and only after than can it be lined up with the product for delivery. But where is the product in its development? Has it been lab tested on mice or solicitors or whatever yet? Then it will need a safety and tolerability test (like Val 201 had and then stopped dead).

Time isn't a problem if the money is there but....

That post was written by Jason Pugh! Well known for ramping or deramping depending on whether he is currently invested or not! PLEASE DO NOT TAKE THIS SERIOUSLY WITHOUT SEEING SOME RELIABLE EVIDENCE.

Badsterman

You mention:

"Integrated Design of a Membrane-Lytic Peptide-Based Intravenous Nanotherapeutic Suppresses Triple-Negative Breast Cancer" - Published in Advanced Science (2022) regarding the CLX001 project."

"Development of membrane-active peptide therapeutics in oncology" - Published in the Journal of Peptide Science (2023), covering the development of CLX001."

Were Valirx involved in contributing to these two acticles?

I would say that the normal sequence of events is:

1) a biotech company develops ground-breaking science (this is obviously a long term process)

2) this is published and presented at conferences until such a time that the scientific community is seriously interested (this also can take a long time). This can take place in parallel with the development of the science.

3) only then do commercial people get seriously involved i.e. there is a definite product to sell and real interest in the product from scientists

Have any of Valirx's products reached stage 3? In other words, is there any evidence that pharma are keen on any of Valirx's products?

'......posts on here are by the uninvested...'

A question to ponder is 'why are they not invested?' Could it be that rather than being underwater (as every long term holder in VAL has to be) they are looking at the potential for any return on an investment here, and not liking the look of it. If I thought there was money to be made here by any means rather than frantic trading on pumped spikes then I'd happily put some cash in. As some may remember, I spent a long time looking at VAL and trying to find a reason for investment - none was ever apparent, but there was often a clamour of 'go on, how low can it go from here?' That was before the last consolidation with the share at about 1.3p. It could be the price two consolidations ago, but I'll be generous. That last consolidation would have reduced 5,000 pounds to 40 quid, and that's before any subsequent share price decline. And as things stand now, the sp is slurping down to the last placing price. So maybe that's why a lot of long term watchers still feel that the enthusiasm of the drum bangers isn't matched by the cold hard business facts in existence, and trips to San Diego look more like a hopeless holiday than any imminent breakthrough, especially with the apparent fossilisation of any scientific advancements here.

Fair point Ray, but...

A quick search reveals plenty of published research and peer reviewed science (I could find more).

Integrated Design of a Membrane-Lytic Peptide-Based Intravenous Nanotherapeutic Suppresses Triple-Negative Breast Cancer" - Published in Advanced Science (2022) regarding the CLX001 project.

"Development of membrane-active peptide therapeutics in oncology" - Published in the Journal of Peptide Science (2023), covering the development of CLX001.

VAL401 Peer-Reviewed Article - Published in the European Journal of Drug Metabolism and Pharmacokinetics (2018/2019), detailing results of the Phase II trial for lung cancer treatment.

Investegate

Epigenomics Publication - Research published in Epigenomics regarding the enhancement of Carboplatin efficacy in prostate cancer.

The Globe and Mail

Patient-Derived Cancer Models Data - Published data presented at AACR (2026), showcasing a framework for digital avatars with patient-derived cancer models for precision oncology.

Our Corporate Development Manager should have quite an armoury of science to backup his sales effort, yet he's delivered nothing.

You've got to ask the question as to what exactly does Valirx bring to each of these partnerships?

One way of answering that question is to look at the scientific papers being published as a result of these partnerships.

Are there any?

Another mischief-maker joins the Val historical society

I’m posting on a share where I have an investment. The majority of posts on here are by the uninvested with nothing else in life to keep them amused other than referring to history lessons.

Last Aug/Sept, IMM, specialising in peptides like Val, increased by 1028% in 24 days. An increase of just half that size for Val would see an SP of 1.57p, all 0.5p and 1.3p warrants exercised – putting a further £5m in Val’s bank.

Porky’s ‘guaranteed’ March placing has already fallen by the wayside. How long before other losers start drifting off as they realise all their efforts are in vain.

19 likes

Can only be a VAL employee

Desperate times my friend : )

Until Mark ousts his £90k secretary and generates more than zero revenue it’s confetti junction every few months #shambles .

Apparently he was in talks with with three companies - Bird's custard, one that made sponge fingers, and one that made multicoloured chocolate sprinkles. He ended up disappointed, saying they wouldn't trifle with him.

These are exciting times if Mark is considering creating a custard pie subsidiary

"None of the bigger holders are selling."

They cannot sell judging on the amount the MMs have on offer at 0.308p...

See if its still funny when shareholders get clobbered with a .12 or .14 placing and take a 50 0r 60% hit shortly

Then again, im sure the champagne corks will be popping if he if gets it over the line, yet again, who cares about the Share price and making the business viable as long as you can keep milking the cash cow and keep the gravy train on the tracks.

Excellent post Notpot and heartily recommended.

On a more serious note, the other Mark has taken up the challenge to solve one of the great unsolved mysteries of physics. One that has baffled many great scientists including Einstein.

How can chopsticks be used to eat a custard pie?

A bit rambling there Notpot, but on a more serious note that may be of use to prospective 'investors' looking in - when do you think the next placing is likely to occur, given the current lack of any other source of funding of any note?

Some may be wondering why Nick shows such resentment towards Mark Treharne, carrying a grudge around like an expired warrant he can’t quite bring himself to tear up. They have history.

Their paths first crossed in a Butlins nativity play many years ago when Mark was cast as Joseph and the older Nick as a stand-in for the donkey’s rear end. That was bad enough, but the combination of rogan josh and stage-fright saw the donkey’s backside become the talk of Butlins for the rest of the week. To this day, Nick swears he was simply improvising but has never forgiven the young Mark for supressing a grin.

The next chance meeting was at a party. Mark entered, nodded, and everyone said hello. Nick walked in, tripped on his shoelace, and pretended it was part of a dance move. His attempt at chatting up the stunning blonde went no better, with his Lynx Africa deodorant sparking her sneezing fit. Mark came to the rescue, “Let’s get some fresh air, it may help.” It did. Nick spent the rest of the night near the speakers, pretending he liked the music.

Years later, their paths crossed again at a broker’s five a side tournament. Mark scored a hat trick and Nick an own goal so spectacular it was briefly nominated for Goal of the Month. Mark patted him on the back and said, “unlucky, mate.” Nick went for a cold shower.

During the post-match cuppa, Mark took the last ginger nut that Nick had been eying for ten minutes, before recognising the blonde linking Mark’s arm. Nick looked at the empty biscuit plate, then at Mark, then at the blonde. He was mentally composing an LSE post even as he left the room.

In the office, novice Mark mastered the Bloomberg shortcuts in 3 days while Nick accidentally changed the terminal language to Chinese and in error bought 5m yuan of shares in a novelty chopsticks venture. Mark walked past just as the confirmation flashed up. Nick minimised the screen a second too late. Later, at the Christmas party, Mark won “Best Newcomer” while Nick won fifth prize in the raffle, ironically a presentation box of Lynx Africa. Mark congratulated him warmly. Nick said through gritted teeth, “it was nice to be recognised.”

The final straw came when, as Nick was typing an LSE reply in a packed office, Mark commented,

“Good post. Your handle - is that Viera as in former Gunner, Patrick?”

“Of course”, said Nick bristling.

“Didn’t Vieira have two ‘i’s? “

The whole office froze when Nick snapped,

“Of course he had 2 eyes”.

At the next office party, everyone bar Nick turned up wearing a patch over one eye.

Nick never understood why.

🤔🤔

I wonder if we will see the formation of a wholly-owned subsidiary company dedicated to the conversion of lead into gold? Imo it would have more chance of commercial success than Val201 has.

Half year to June 25 · Administrative expenses £828,444.

Looks like full year results will show little cash remaining. So far the company has made money from selling shares and it will now proceed down the usual. Discounted placing is now being planned.

Watch out for sudden rise in the share price where prices are engineered or orchestrated to unload yet to be issued shares. Basically pre-selling.

The annual report must be due soon so we’ll soon find out whether or not this is true!

With Administrative expenses of £1,976,283 for the year ended 31 December 2024 and probably a similar amount for year ending 2025 the £1M it raised 6 months ago must be gone and plans must be afoot for the next placing.

Val enthusiast Laura2022 has been in action in BMV plugging another share immediately after today's placing which follower a huge pump and dump on BMV.

Anyone pondering the sincerity and honesty of the pump brigade would do well to watch Laura's posting tactics and be wary of those who flog a dead horse and then when it collapses, immediately point to an alternative 'about to blow' hot stock to tempt you to jump in to recover the losses you sit on which they have helped create.

I imagine Laura2022 is part of the same crew beckoning wide-eyed unreserved innocents into here.

Maybe a 3k director purchase ?

Whoever advised that needs to take a £90k pay cut !! lol

If desperation means observing and making judgements based on past performance, available facts and reasonable conjecture, then I must qualify as desperate.

I'd have thought 'desparate' is more on the lines of someone who blanks anyone who doesn't agree with them and counters rational argument with a mixture of abuse and fantasy, like some sort of cocaine-fuelled Mystic Meg.

Desperation stakes for the Val historians. 6 filtered posts on the trot. Love it!

I’ve always appreciated green bands: The Dubliners, U2 or my all-time favourite, Thin Lizzy. Quite appropriate to the naysayers on here, “Don’t believe a word”. 👩🏾‍🎤 🤣

@Raty - ha ha that was quick, absolutely spot on.

@RayP - Loved that, the VAL horse will be the one at the back.

See at least we can all have a bloody good laugh at the inevitable!

Here's last year's race. Let's hope this year's is equally exciting.

https://www.msn.com/en-gb/video/viral/london-pantomime-horse-race-2025-brits-take-part-in-bonkers-race-through-streets-of-greenwich/vi-AA1Skhjx

Consolidations are 125/1 - but that's not odds of course.